Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|July 3, 2017
CSPG4: a prototype oncoantigen for translational immunotherapy studiesValeria Rolih, Giuseppina Barutello, Selina Iussich, et al.
Cancers|December 11, 2025
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of CancerLidia Tarone, Antonella Iacoviello, Antonino Di Lorenzo, et al.
International Journal of Molecular Sciences|March 15, 2018
Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for ImmunotherapyGiuseppina Barutello, Valeria Rolih, Maddalena Arigoni, et al.
Veterinary and Comparative Oncology|January 14, 2021
Evaluation of prognostic impact of pre-treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4-antigen electrovaccination: an explorative studyMariateresa Camerino, Davide Giacobino, Selina Iussich, et al.
Life (Basel, Switzerland)|December 23, 2022
Improving Osteosarcoma Treatment: Comparative Oncology in ActionLidia Tarone, Katia Mareschi, Elisa Tirtei, et al.
Scientific Data|February 2, 2024
A single cell RNAseq benchmark experiment embedding "controlled" cancer heterogeneityMaddalena Arigoni, Maria Luisa Ratto, Federica Riccardo, et al.
Molecular Aspects of Medicine|December 4, 2024
Cancer vaccines: Target antigens, vaccine platforms and preclinical modelsFrancesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2018
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporterRoberto Ruiu, Valeria Rolih, Elisabetta Bolli, et al.
Cancer Immunology Research|June 14, 2020
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast CancerLaura Conti, Elisabetta Bolli, Antonino Di Lorenzo, et al.
Oncotarget|October 31, 2015
Novel insights into Notum and glypicans regulation in colorectal cancerMariangela De Robertis, Maddalena Arigoni, Luisa Loiacono, et al.
Pageof 5